Navigation Links
French Fries In Cancer Controversy In China

Yet again the French fries seem to be entangled in a health controversy now in China. Scientists in China have found that acrylamide, a probable human cancer causing agent, in potato fries exceeds the limit in drinking water set by the World Health Organization (WHO) by 500 times.//

The Chinese Ministry of Health said that measures have been taken to control the possible harm of fried-food-borne acrylamide in humans.

In April, the Chinese Ministry of Health published an assessment report on the risk of acrylamide saying that tests in animals have indicated that acrylamide is a known probable human carcinogen. Recently, scientists have found that potato fries possess acrylamide at levels 500 times higher than that allowed in drinking water set by the WHO.

The Ministry of Health particularly reminds the public that based on the results from a Chinese food contaminant surveillance program, high levels of acrylamide are present in fried potatoes, malt tea, instant coffee, maize tea, fried grain-based foods, and baked grain foods. The real content of acrylamide varies depending upon the type of food, cooking time and temperature.

Acrylamide could potentially cause cancer in humans. Animal tests suggest such a probability. Epidemiological studies on professional exposure to acrylamide found that long term exposure to low doses of acrylamide can cause a range of health conditions including sleepiness, disturbed emotion, and memory loss, among others.

The Chinese actions may be prompted by the high profile media attention of the California lawsuit against fast-food giants. Last Friday, California Attorney-General Bill Lockyer filed a suit to request nine snack and fast-food providers to put a warning over the presence of acrylamide in some of their foods.

The lawsuit received a strong response from the food industry, resulting in a lawsuit being filed by a group to request California to withdraw its original l
'"/>




Page: 1 2

Related medicine news :

1. French and wine: inseparable and just perfect?
2. French Doctors Successfully Separate Twins Joined At Spine
3. McDonalds: French Fries, Transparent to more Trans -Fats
4. Chikungunya Epidemic On French Island Claims 52 lives
5. French fries by McDonalds fries in another controversy
6. French Minister To Visit La Reunion Island To Monitor Chikungunya Epidemic
7. Chikungunya Fever: French Government struggling to Tackle the Mosquito Menace
8. New Breast Cancer Dictionary To Be Brought Out By French League Against Cancer
9. French Face Transplant Patient Reports Feeling of Sensation in New Face
10. French Ship docks in Alang, Gujarat
11. French Surgeons Take Off for First Gravity-free Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: French Fries Cancer Controversy China

(Date:11/21/2008)... MediConnect CEO, Amy Rees And...ary of Health, Michael Leavitt, in the 2008 Nation... Salt Lake City (Vocus) November 20...invited to participate with U.S. Secretary of Heal...n Personalized Health Care. The Summit brings tog...
(Date:11/21/2008)... Texas Monthly Magazine announ...r Dentist" award given to elite dentists in T... once again nominated a top practitioner in the ar... Austin, TX (PRWEB) November 21, 2008-- Dr. Mich...ted as a "Texas Monthly Super Dentist" f...
(Date:11/20/2008)...g-term use of a macrolide antibiotic may reduce th...rate to severe chronic obstructive pulmonary disea... London-based study. , "Our results show a sign...cing exacerbation frequency and severity with mode...er, Terence A. R. Seemungal, Ph.D., and Jadwiga We...
(Date:11/20/2008)...YORK Nov. 19, 2008 The American Cancer Society ... and largest non-governmental funder of cancer res...r, the Medal of Honor, to four Americans who have ...t cancer. This year,s winners, who will receive th...r Society,s annual meeting in New York City, are: ...
Breaking Medicine News(10 mins):Health News:MediConnect Participates in 2008 National Health Summit 2Health News:Texas Super Dentist Awards Announced--Dr. Michael McCarty From Austin Smiles Is Awarded For The Third Year In A Row 2Health News:Long-term antibiotics reduce COPD exacerbations, raise questions 2Health News:Long-term antibiotics reduce COPD exacerbations, raise questions 3Health News:Scientists honored for contributions to cancer fight 2Health News:Scientists honored for contributions to cancer fight 3Health News:Scientists honored for contributions to cancer fight 4Health News:Scientists honored for contributions to cancer fight 5
... UK are demanding complete overhauling of, the Hum...following a judicial rap it has received. The H...egulator had unlawfully obtained warrants to searc...umentary. The Human Fertilisation and Embryology ...
... Klass has followed in the footsteps of actress De...year-old I'm A Celebrity star, wearing only her en...d for Glamour magazine's British edition. "You do...ly or my bum look big'. You just think, 'Wow, I'm ...
... Friday called for taking advantage of the benefit...tele-radiology to help the needy in rural areas in...a visit to the digital radiology centre at Electro...CIL), which is working towards providing low cost ...
...trict are grappling to fight against a deadly vira...ed at least 30 children in the past five months. D... Medical College, said that the hospital run by th...ents since January out of whom 30 children have so...
Other Medicine News:Health News:UK Doctors Demand Overhauling of Fertility Regulatory Authority 2
(Date:11/20/2008).... 20 PAREXEL Internation... biopharmaceutical services provider, today announ...provide regulatory consulting and clinical researc...ce, PAREXEL now has locations throughout five impo...which also include Argentina, Brazil, Chile, and M...
(Date:11/19/2008)... Study did not achieve statistical significance ,...all/ -- Pharmos Corporation (Nasdaq: PARS ) toda...al of its topical NanoEmulsion (NE) drug delivery ...amine. , , The multi-center, randomized, do...he safety and efficacy of the Company,s 3% Diclofe...
(Date:11/19/2008)...5 Million Payment from Roche- , , MONTVALE,...armaceuticals Corp. (Nasdaq: MEMY ) today announ...ts Phase 2 trial of R3487/MEM 3454, its lead alpha...ment associated with schizophrenia (CIAS). The Co...rial, triggering a $5.0 million payment from its p...
(Date:11/18/2008)...Va., Nov. 18 Forty-two ...at a November national forum to consider cutting-e...ealth and national economy from outbreaks of dange...today. , , Among those innovations: , ,...ican kitchen table that detects highly contagious ...
Breaking Medicine Technology:PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 2PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 3PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 4Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 342 Top U.S. Scientists and Specialists Explore Cutting-Edge Innovations to Defend America From Dangerous Zoonotic Diseases 2Healthcare Businesswomens Association Names Genentechs Leonard Kanavy Vice President Commercial Operations as the 2008 Honorable Mentor 12942 1Healthcare Businesswomens Association Names Genentechs Leonard Kanavy Vice President Commercial Operations as the 2008 Honorable Mentor 12942 2Healthcare Businesswomens Association Names Genentechs Leonard Kanavy Vice President Commercial Operations as the 2008 Honorable Mentor 12942 3Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2007 Financial Results 3569 1Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2007 Financial Results 3569 2Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2007 Financial Results 3569 3Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2007 Financial Results 3569 4Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2007 Financial Results 3569 5Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2007 Financial Results 3569 6Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2007 Financial Results 3569 7Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2007 Financial Results 3569 8Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2007 Financial Results 3569 9Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2007 Financial Results 3569 10Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2007 Financial Results 3569 11Mylan Announces Amendment to Bystolic 28TM 29 28Nebivolol 29 Agreement 3565 1Mylan Announces Amendment to Bystolic 28TM 29 28Nebivolol 29 Agreement 3565 2Mylan Announces Amendment to Bystolic 28TM 29 28Nebivolol 29 Agreement 3565 3New research suggests biofuel blending is often inaccurate 2336 1New research suggests biofuel blending is often inaccurate 2336 2New research suggests biofuel blending is often inaccurate 2336 3
... of the most modern lithotripters available today ...om being designed for the treatment of the entire ...LITH SLX can also be employed for a variety of oth...e for the treatment of gallstones or for orthopead...
Used for temporary control of male urinary incontinence due to surgery or neurogenic disorder. Supplied non-sterile. Reusable. Intended for single patient use only.
Used for temporary urine collection. The leg bag is designed for use with the Non-Adhesive Silicone Condom Catheter. Supplied non-sterile. Reusable. Intended for single patient use only.
The latex free, hydrophilic Self-Cath Plus is designed for single use, intermittent self-catheterization. The unique hydrophilic coating activates immediately upon exposure to water for fast, clean
Medicine Products: